Key Points Recursion Pharmaceuticals developed a promising artificial intelligence (AI) platform for drug discovery and development. The company's clinical-stage pipeline is just the tip of the iceberg of its opportunities. This biotech stock is a high-risk, potentially high-reward proposition. 10 stocks we like better than Recursion Pharmaceuticals › Some investors closely monitor the portfolios of billionaires to get ideas. Another approach, however, is to examine the stocks held by highly succ ...